GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 74 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 24 | -97.7% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 1,024 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -14.3% | 1,024 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +75.0% | 1,024 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 1,024 | +2.4% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -55.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | -7.7% | 1,000 | -9.3% | 0.00% | – |
| Q3 2016 | $13,000 | +62.5% | 1,103 | +10.3% | 0.00% | – |
| Q2 2016 | $8,000 | +60.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | -22.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $12,000 | -7.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +62.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -38.5% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | +44.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | -30.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $13,000 | +8.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $12,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2013 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|